Trinity Capital Inc. Provides $12M Growth Capital To Delphinus Medical Technologies, Inc.
Portfolio Pulse from Happy Mohamed
Trinity Capital Inc. (NASDAQ:TRIN) has committed $12 million in growth capital to Delphinus Medical Technologies, a medical imaging company. The funds will be used to scale operations and expand the impact of Delphinus' SoftVue 3D Whole Breast Ultrasound Tomography System, a FDA-approved technology for early breast cancer detection.
August 22, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Trinity Capital's investment in Delphinus Medical Technologies could potentially enhance its portfolio and generate returns in the long run.
Trinity Capital's investment in Delphinus, a company with a FDA-approved technology, could potentially enhance its portfolio. The success of Delphinus' technology in the market could generate returns for Trinity in the long run.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100